Area of research
Genetics · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Glioma Diagnosis and Treatment, Advanced MRI Techniques and Applications, MRI in cancer diagnosis, and Brain Metastases and Treatment.
RANO criteria for response assessment of brain metastases based on amino acid PET imaging
Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO <i>resect</i> group
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions
Towards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation
“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade
Novel <i>SOX10</i> indel mutations drive schwannomas through impaired transactivation of myelination gene programs
Liquid biopsy in gliomas: A RANO review and proposals for clinical applications
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1
Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type Glioblastoma
eScholarship (California Digital Library) 2022cited by 44position: middle
GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade <i>IDH</i>-mutant gliomas
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
Loneliness and symptom burden in oncology patients during the COVID‐19 pandemic
EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma
Intracranial mesenchymal tumors with FET‐CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas
Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to ‘Polymorphous low-grade neuroepithelial tumor of the young’
Association of Maximal Extent of Resection of Contrast-Enhanced and Non–Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas
Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence
Intracranial mesenchymal tumor with FET‐CREB fusion—A unifying diagnosis for the spectrum of intracranial myxoid mesenchymal tumors and angiomatoid fibrous histiocytoma‐like neoplasms
Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor
Characterization of serial hyperpolarized 13C metabolic imaging in patients with glioma
Oncology patients’ perceptions of and experiences with COVID-19